aflibercept Articles

Bayer files for Japanese approval of Eylea for macular edema following CRVO

7 January 2013

Bayer to file for EU approval of aflibercept for central retinal vein occlusion

21 February 2012

Sanofi-Aventis and Regeneron’s Zaltrap improves OS in Ph III colon cancer study

28 April 2011

Sanofi-Aventis/Regeneron’s aflibercept fails in Ph III NSCLC study

14 March 2011

Ph III studies show Bayer and Regeneron VEGF Trap-Eye in wet AMD meets primary endpoints versus Lucentis

22 November 2010

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end